West Pharmaceutical Services (WST) Change in Cash (2009 - 2026)

West Pharmaceutical Services (WST) has reported Change in Cash for 18 consecutive years, with -$85.6 million the latest figure, recorded in Q2 2026.

• Quarterly Change in Cash fell 181.14% year-over-year to -$85.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$73.9 million (down 216.38% YoY) and the FY2025 annual result came in at $306.7 million, up 183.05% from the prior year.
• Change in Cash rose to -$85.6 million in Q2 2026 per WST's latest filing, from -$269.9 million in the prior quarter.
• Over the last five years, Change in Cash for WST reached as high as $165.3 million in Q4 2022 and fell as low as -$269.9 million in Q1 2026.
• A 5-year average of -$18.2 million and a median of -$7.2 million in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2024 — Change in Cash tumbled 3051.25% — and 2025, when it surged 2684.13%.
• Year by year, Change in Cash stood at $165.3 million in 2022, then tumbled by 127.04% to -$44.7 million in 2023, then soared by 85.91% to -$6.3 million in 2024, then jumped by 2684.13% to $162.8 million in 2025, then sank by 152.58% to -$85.6 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$85.6 million, -$269.9 million, and $162.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.